-
公开(公告)号:US11427540B2
公开(公告)日:2022-08-30
申请号:US17387648
申请日:2021-07-28
发明人: Kiran Reddy , Margaret S. Lee , Gabriel Maurice Belfort , Sapna Makhija Garad , Mahesh Padval , Randall Wagner
IPC分类号: C07D211/34 , A61K9/20 , A61K9/00 , A61K47/38 , C07D211/26
摘要: Described herein, in part, are dosage forms and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a T-type calcium channel, such as epilepsy and epilepsy syndromes (e.g., absence seizures, juvenile myoclonic epilepsy, or a genetic epilepsy), tremor (e.g., essential tremor), and psychiatric disorder (e.g., mood disorders (e.g., major depressive disorder)). The present invention further comprises methods for modulating the function of a T-type calcium channel.
-
公开(公告)号:US12077502B2
公开(公告)日:2024-09-03
申请号:US17871065
申请日:2022-07-22
发明人: Kiran Reddy , Margaret S. Lee , Gabriel Maurice Belfort , Sapna Makhija Garad , Mahesh Padval , Randall Wagner , Marion Wittmann
IPC分类号: C07D211/34 , A61K9/00 , A61K9/20 , A61K9/48 , A61K31/445 , A61K47/38 , A61P25/14 , C07D211/26
CPC分类号: C07D211/34 , A61K9/0053 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2054 , A61K9/4825 , A61K9/4858 , A61K9/4866 , A61K31/445 , A61K47/38 , A61P25/14 , C07D211/26 , C07B2200/13
摘要: Described herein, in part, are dosage forms and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a T-type calcium channel, such as epilepsy and epilepsy syndromes (e.g., absence seizures, juvenile myoclonic epilepsy, or a genetic epilepsy), tremor (e.g., essential tremor), and psychiatric disorder (e.g., mood disorders (e.g., major depressive disorder)). The present invention further comprises methods for modulating the function of a T-type calcium channel.
-
公开(公告)号:US20230192612A1
公开(公告)日:2023-06-22
申请号:US17871065
申请日:2022-07-22
发明人: Kiran Reddy , Margaret S. Lee , Gabriel Maurice Belfort , Sapna Makhija Garad , Mahesh Padval , Randall Wagner , Marion Wittmann
IPC分类号: C07D211/34 , A61K9/20 , A61K9/00 , A61K47/38 , C07D211/26 , A61P25/14 , A61K9/48 , A61K31/445
CPC分类号: C07D211/34 , A61K9/2009 , A61K9/2013 , A61K9/2054 , A61K9/0053 , A61K47/38 , C07D211/26 , A61P25/14 , A61K9/2018 , A61K9/4825 , A61K9/4858 , A61K9/4866 , A61K31/445 , C07B2200/13
摘要: Described herein, in part, are dosage forms and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a T-type calcium channel, such as epilepsy and epilepsy syndromes (e.g., absence seizures, juvenile myoclonic epilepsy, or a genetic epilepsy), tremor (e.g., essential tremor), and psychiatric disorder (e.g., mood disorders (e.g., major depressive disorder)). The present invention further comprises methods for modulating the function of a T-type calcium channel.
-
公开(公告)号:US12049448B2
公开(公告)日:2024-07-30
申请号:US17871065
申请日:2022-07-22
发明人: Kiran Reddy , Margaret S. Lee , Gabriel Maurice Belfort , Sapna Makhija Garad , Mahesh Padval , Randall Wagner , Marion Wittmann
IPC分类号: C07D211/34 , A61K9/00 , A61K9/20 , A61K9/48 , A61K31/445 , A61K47/38 , A61P25/14 , C07D211/26
CPC分类号: C07D211/34 , A61K9/0053 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2054 , A61K9/4825 , A61K9/4858 , A61K9/4866 , A61K31/445 , A61K47/38 , A61P25/14 , C07D211/26 , C07B2200/13
摘要: Described herein, in part, are dosage forms and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a T-type calcium channel, such as epilepsy and epilepsy syndromes (e.g., absence seizures, juvenile myoclonic epilepsy, or a genetic epilepsy), tremor (e.g., essential tremor), and psychiatric disorder (e.g., mood disorders (e.g., major depressive disorder)). The present invention further comprises methods for modulating the function of a T-type calcium channel.
-
-
-